Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03127774 · ClinicalTrials.gov registry record · Phase 2
Surgery and Heated Intraperitoneal Chemotherapy for Adrenocortical Carcinoma
A Phase 2 study of Peritoneal Carcinomatosis and Adrenocortical Carcinoma, sponsored by Columbia University.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT03127774 is a Phase 2 study of Peritoneal Carcinomatosis and Adrenocortical Carcinoma that is actively recruiting participants, run by Columbia University. The registered enrollment target is 30 participants, below the 58-participant average among 14 other Peritoneal Carcinomatosis trials with a reported enrollment target (48% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03127774, a Phase 2 study of Peritoneal Carcinomatosis and Adrenocortical Carcinoma, is actively recruiting participants, sponsored by Columbia University.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
Objectives: \- To determine intraperitoneal (IP) progression free survival after optimal debulking and heated intraperitoneal chemotherapy (HIPEC) with cisplatin in patients with IP spread of adrenocortical cancer. \- Determine morbidity of this procedure in this patient population. \- Determine the impact of surgery and HIPEC on quality of life (QOL) and hormone excess. \- Examine patterns of recurrence (local versus systemic). \- Determine overall survival after optimal debulking and HIPEC in patients with IP spread of adrenocortical cancer.
Conditions Studied
Interventions
- DRUG Cisplatin
- DRUG Sodium thiosulfate
- PROCEDURE Cytoreductive surgery
Study Locations (1)
New York
- Columbia University Medical Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2017-09-22 |
| Est. Completion | 2025-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03127774
The ClinicalTrials.gov registry entry for NCT03127774 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 58-participant average among 14 other Peritoneal Carcinomatosis trials with a reported enrollment target (48% lower). The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Peritoneal Carcinomatosis appearing as the primary indexed condition, and to 3 interventions - of which Cisplatin is the first listed.
NCT03127774 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT03127774 about?
NCT03127774 is a clinical study titled "Surgery and Heated Intraperitoneal Chemotherapy for Adrenocortical Carcinoma". Objectives: \- To determine intraperitoneal (IP) progression free survival after optimal debulking and heated intraperitoneal chemotherapy (HIPEC) with cisplatin in patients with IP spread of adrenocortical cancer. \- Determine morbidity of this procedure in this patient population. \- Determine ...
What is the current status of trial NCT03127774?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 30 participants. The study started on 2017-09-22. Estimated completion is 2025-12.
What conditions does trial NCT03127774 study?
This clinical trial studies the following conditions: Peritoneal Carcinomatosis, Adrenocortical Carcinoma.
What interventions are being tested in trial NCT03127774?
The interventions under investigation include: Cisplatin (DRUG), Sodium thiosulfate (DRUG), Cytoreductive surgery (PROCEDURE).
Who is sponsoring clinical trial NCT03127774?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03127774 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Peritoneal Carcinomatosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study of Radspherin® in Patients With Primary Advanced Epithelial Cancer, With Peritoneal Metastasis That Are Homologous Recombination Proficient Scheduled to Undergo Neoadjuvant Chemotherapy and Interval Debulking Surgery
RECRUITING · Phase 2
-
Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer
RECRUITING · Phase 2
-
Heated Versus Aerosol-based Laparoscopic Chemotherapy for Cancer That Has Spread to the Peritoneum (Abdominal Lining)
RECRUITING · Phase 2
-
Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity
RECRUITING · Phase 2
-
Flat Dose vs. Weight-based IP Chemotherapy for CRS/HIPEC
RECRUITING · Phase 2
-
Study of Intravenous and Intraperitoneal Paclitaxel and Oral Nilotinib for Peritoneal Carcinomatosis From Colorectal, Appendiceal, Small Bowel, Gastric, Cholangiocarcinoma, Breast, Ovarian, or Other Gynecologic Primary Cancer
ACTIVE NOT RECRUITING · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.